Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.62 |
| ▸ | NPY1R | P25929 | 9/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.62 |
| ▸ | NPY2R | P49146 | 5/20 | 0.62 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.51 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20715010 | 1.00 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL22009523 | 1.00 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL20715015 | 1.00 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL20714935 | 0.99 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL20714938 | 0.99 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL20715043 | 0.97 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL14509067 | 0.96 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL14509088 | 0.96 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL20714987 | 0.95 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL22010058 | 0.95 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200157144-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200157144-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | NGLY1, GLMN, GMPS | NPY4R 1178/4885NPY1R 538/4885NPY5R 704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.